Robuta

https://www.fiercepharma.com/ Fierce Pharma Biopharma News & Insights Fierce Pharma delivers breaking news and analysis about drug companies, the FDA and the broader pharma industry, including manufacturing, marketing and finance. fierce pharmabiopharma newsinsights https://synthesis-co.typeform.com/biopharma Total Evidence Awareness for Biopharma AI-powered evidence synthesis processing 100,000+ documents in weeks. Gain competitive advantage with total information awareness in pharma. Accelerate launch... totalevidenceawarenessbiopharma https://www.biopharmaglobal.com/ FDA & EMA Regulatory Affairs Consulting Services | BioPharma Global regulatory affairs consultingfdaemaservicesbiopharma https://www.biopharmadive.com/ Biotech and Pharma Industry News | BioPharma Dive BioPharma Dive provides news and analysis for biotech and biopharmaceutical executives. We cover topics like clinical trials, drug discovery and development,... biotech and pharmaindustry newsbiopharmadive https://informaconnect.com/bioeurope/ BIO-Europe 2026 | Global Biopharma Partnering Event | Cologne, Germany Join 8,000+ life science professionals at BIO-Europe 2026 in Cologne, 9-11 November. Connect with global biopharma leaders and drive strategic partnerships... biopharma partneringeuropeglobaleventcologne https://btllc.solutions/ Home - Biopharma Technology LLC Dec 13, 2025 - Biopharma Technologies LLC biopharmatechnologyllc https://www.prnewswire.com/news-releases/simtra-biopharma-solutions-announces-strategic-purchase-to-expand-us-manufacturing-capacity-for-injectable-medicines-302513753.html?tc=eml_cleartime Simtra BioPharma Solutions Announces Strategic Purchase to Expand U.S. Manufacturing Capacity for... Jul 25, 2025 - /PRNewswire/ -- Simtra BioPharma Solutions, a leading global contract development and manufacturing (CDMO) specializing in injectable medicines, announced... https://www.biopharmadive.com/news/astellas-kelonia-cell-therapy-in-vivo-partnership/707702/ Astellas teams up with startup Kelonia to make ‘in vivo’ cell therapies | BioPharma Dive Kelonia will receive $40 million upfront through the partnership, and could receive $35 million more if Astellas opts into another program. https://exagen.com/partnerships/biopharma-solutions/ Biopharma Solutions - Research & Discovery – Exagen Inc. Oct 26, 2023 - We offer a comprehensive menu of tests covering complement activation in autoimmune diseases, including proprietary diagnostic testing. biopharma solutionsresearchdiscoveryinc https://www.advantapure.com/ High-Purity Tubing and Aseptic Hose Assemblies for Biopharma | AdvantaPure Apr 28, 2026 - AdvantaPure is an ISO 9001:2015 certified manufacturer of high-purity tubing, aseptic hose, and single use systems for biopharma and pharma applications. high purityhose assembliesfor biopharmatubingaseptic https://guardanthealth.com/precision-oncology/biopharma-solutions/translational-research/ BioPharma Solutions | Translational Research Apr 16, 2026 - Discover how our translational research services support your drug development journey at every critical stage. biopharma solutionstranslationalresearch https://www.crozetbiopharma.com/ Crozet BioPharma Crozet is a vaccine development firm offering biopharmecuticals an alternative to hiring or diverting costly personnel to the development of a pipline product. crozetbiopharma https://www.grifols.com/en/home Biopharma & Healthcare Solutions | Grifols Explore Grifols' comprehensive, innovative and patient-centric biopharma and healthcare solutions. healthcare solutionsbiopharmagrifols https://aytubio.com/ Home - Aytu BioPharma Jul 25, 2025 - Medicines Made for Life. Aytu BioPharma is a pharmaceutical company focused on advancing innovative medicines for complex central nervous system (CNS) diseases... biopharma https://www.thermofisher.com/blog/analyteguru/ AnalyteGuru - Your educational resource for biopharma, pharma, environmental, food and agriculture,... Your educational resource for biopharma, pharma, environmental, food and agriculture, industrial, and clinical labs educational resourcefor biopharmafood andanalyteguru https://aeonbiopharma.com/ Activating the full potential of therapeutic botulinum toxin | AEON Biopharma AEON is developing ABP-450, a proprietary botulinum toxin, to unlock the promise of therapeutic botulinum toxin to treat nervous system-related conditions full potentialbotulinum toxinactivatingtherapeuticaeon https://www.accordbiopharma.com/report-adverse-events-and-complaints/ Report - Accord BioPharma Nov 7, 2025 - Report Adverse Events and Complaints If you have questions or want to report a complaint or an adverse event, contact us.Registered Office Accord reportaccordbiopharma https://abzena.com/ Abzena | Bioconjugates & Biologics CDMO+CRO | Biopharma May 5, 2026 - Abzena is a fully integrated biopharmaceutical CDMO+CRO for antibodies, ADCs, AOCs, RDCs, vaccines, from discovery thru commercial. biologics cdmobioconjugatescrobiopharma https://www.biopharmadive.com/spons/genai-and-real-world-data-in-pharma-4-questions-to-fuel-effective-insights/753774/ GenAI and real-world data in pharma: 4 questions to fuel effective insights | BioPharma Dive To truly unlock the power of RWD, GenAI must go beyond checking a box or staying on trend. https://synergbiopharma.com/ Strategic Development & Delivery Partner to Biopharma Innovators | Syner-G We partner with biopharma innovators to turn scientific breakthroughs into real-world therapies faster, smarter, and with greater impact. strategic developmentdelivery partnerbiopharmainnovators https://enable-bio.webflow.io/solutions/biopharma Biopharma | Enable Medicine Leverage Enable Medicine's integrated platform to derive actionable insights and meet your program timelines. biopharmaenablemedicine https://finance.yahoo.com/news/immix-biopharma-present-guggenheim-2nd-124500735.html Immix Biopharma to Present at the Guggenheim 2nd Annual Healthcare Innovation Conference Oct 14, 2025 - LOS ANGELES, CA, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. (“ImmixBio”, “Company”, “We” or “Us” or ”IMMX”), the global leader in... at the https://www.umoja-biopharma.com/our-science/ Our Science | Umoja Biopharma Jul 12, 2022 - Our platform targets tumors with precision, enabling patients to live longer healthier lives. our scienceumojabiopharma https://tlgcareers.com/recruiting-firm-for-top-biometrics-talent/ Life Sciences Recruitment & Staffing Agency: Biotech & Biopharma Jobs May 7, 2026 - The Lotus Group is a woman-owned recruitment and staffing agency for biotech and biopharma jobs. Take the next step in your career with us! life sciencesstaffing agencyrecruitmentbiotechbiopharma https://finviz.com/news/326619/gt-biopharma-reports-full-year-2025-financial-results GT Biopharma Reports Full Year 2025 Financial Results Stock screener for investors and traders, financial visualizations. full yeargtbiopharmareportsfinancial https://www.biopharmadive.com/news/moderna-coronavirus-vaccine-kids-study-results/608811/ Moderna vaccine safe and spurs immune response in kids, company says | BioPharma Dive The trial results should allow the company to ask the FDA for approval of its vaccine in younger children, just as Pfizer nears a crucial decision for its shot... https://www.healthcarepressmicronesia.com/article/854579601-quantum-biopharma-receives-final-reports-for-two-key-studies-of-its-potential-breakthrough-drug-for-multiple-sclerosis-moving-closer-to-phase-2 Quantum BioPharma Receives Final Reports for Two Key Studies of its Potential Breakthrough Drug for... https://www.sganalytics.com/blog/biopharma-vc-2q25-capital-concentration/ Biopharma VC in 2Q25: Capital Concentrates in De-Risked Assets Sep 11, 2025 - This VC expert post discusses biopharma venture capital deal activity in the second quarter of 2025, offering capital concentration insights. biopharmavccapitalconcentratesde https://interfax.com/newsroom/top-stories/66784/ Guest column: Biopharma and pharma industrial parks - development, difficulties and breakthroughs guest columnbiopharma andindustrial parksdevelopmentdifficulties https://www.propanc.com/contact Contact :: Propanc Biopharma, Inc. (PPCB) biopharmainc https://biopharmaboardroom.com/category/vaccines/page-9.html Latest BioPharma News and In-Depth Analysis | BioPharma BoardRoom Stay ahead of the curve in the biopharma industry with Biopharma Boardroom. Our website offers valuable insights, analysis, and networking opportunities for... biopharma newsand inlatestdepthanalysis https://freedombiopharma.com/ Freedom Biopharma freedombiopharma https://www.biopharmadive.com/news/bristol-myers-zeposia-ulcerative-colitis/579048/ Bristol Myers follows Zeposia launch with positive data from key study | BioPharma Dive The drugmaker's new pill would be the only drug in its class to treat ulcerative colitis, but could face competition from Pfizer, AbbVie and Gilead. https://european-biotechnology.com/tag/dawn-biopharma/ Dawn Biopharma Archives - European Biotechnology Magazine dawnbiopharmaarchiveseuropeanbiotechnology https://www.pharma-iq.com/market-access/videos/live-coverage-chicago-pelican-biopharma-temperature-safe Live Coverage from Chicago: Pelican BioPharma Temperature-Safe Storage and Transport Case storage and transportlive coverage https://www.biopharmadive.com/news/merck-enflonsia-rsv-antibody-fda-approval-clesrovimab/750123/ Merck antibody drug for RSV approved by FDA | BioPharma Dive Known as Enflonsia, the drug will compete for market share with Sanofi and AstraZeneca’s in-demand Beyfortus, which quickly became a blockbuster medicine... approved bymerckantibodydrugrsv https://www.pharmatutor.org/pharma-news/2016/Cti-biopharma-announces-fda-impose-partial-clinical-hold-on-pacritinib-ind CTI BioPharma announces FDA Impose Partial Clinical Hold on Pacritinib IND | PharmaTutor CTI BioPharma Corp. announced that the Company received written communication from the U.S. Food and Drug Administration (FDA) on February 4, 2016, that the... https://simtra.com/what-we-do/product-delivery-options/liquid-vials/ Liquid Vials — Simtra BioPharma Solutions Nov 7, 2025 - Simtra offers flexible filling options for clinical or commercial production of liquid vials. liquid vialsbiopharmasolutions https://www.masontechnology.ie/webinars/webinar-dissolved-oxygen-in-biopharma/ Webinar: Dissolved Oxygen in Biopharma - Mettler Toledo Oct 18, 2024 - Dissolved oxygen levels in an aerobic fermentation or cell culture broth is one of the critical key variables in upstream biomanufacturing. dissolved oxygenwebinarbiopharmamettlertoledo https://markets.businessinsider.com/news/stocks/redhill-biopharma-announces-development-progress-for-rhb-102-1035683985 RedHill Biopharma announces development progress for RHB-102 | Markets Insider RedHill Biopharma (RDHL) announced development progress for RHB-102 in multiple GI indications, including its development, via the accelerated F... development progressredhillbiopharmaannouncesrhb https://www.biopharmadive.com/editors/dalvarado/ Delilah Alvarado | BioPharma Dive delilah alvaradobiopharmadive https://www.biopharmadive.com/news/biomarin-investor-day-reorganization-voxzogo-guidance/726093/ BioMarin, having retrenched, outlines plans for growth | BioPharma Dive The biotech is putting Voxzogo, its drug for skeletal disorders, at the center of plans to grow revenue the rest of this decade and beyond. for growthbiomarinoutlinesplansbiopharma https://www.imapac.com/leadgen360/customised-events LeadGen 360: Tailored Biopharma Events Solutions Engage your target audience with tailored physical, virtual, or hybrid events. Experience unmatched expertise in biopharma event solutions. biopharma eventsleadgentailoredsolutions https://sentrybps.com/ Sentry BPS | Sentry BioPharma Services Jul 18, 2025 - Our state-of-the-art GMP storage facilities guarantee optimal conditions for your products, from temperature control to security. sentrybpsbiopharmaservices https://www.biosimilarspipeline.com/shop/fm-10-f693024-2s-3s-anthracenyl-tert-butyl-methoxy-oxaphosphole-63084 (2S,3S)-Anthracenyl-tert-butyl-methoxy-oxaphosphole | Biopharma BiosimilarsPipeline tertbutylbiopharma https://ir.propanc.com/press-releases?page=14 Press Releases :: Propanc Biopharma, Inc. (PPCB) press releasesbiopharmainc https://business.greaterlowellcc.org/list/category/biotechnology-biopharma-831?o=alpha Biotechnology/BioPharma Category | Greater Lowell Chamber of Commerce Aug 5, 2022 - Greater Lowell Chamber of Commerce | Biotechnology/BioPharma greater lowellbiotechnologybiopharmacategorychamber https://www.biopharmadive.com/news/moderna-flu-covid-combo-vaccine-study-results/695570/ Moderna claims positive results in early study for combo COVID, flu shot | BioPharma Dive The company is planning to start a Phase 3 trial of the vaccine this year, and is targeting a regulatory approval in 2025. https://www.matinasbiopharma.com/investors/sec-filings/all-sec-filings/xbrl_doc_only/1559 Matinas BioPharma Holdings, Inc. Quarterly report pursuant to Section 13 or 15(d) https://tongahealthcaredaily.com/article/910785001-crescent-biopharma-to-present-at-may-investor-conferences Crescent Biopharma to Present at May Investor Conferences | Tonga Healthcare Daily investor conferencescrescentbiopharmapresent https://www.bioworld.com/articles/701884-biopharma-money-raised-jan-1-oct-13-2023?v=preview Biopharma money raised: Jan. 1-Oct. 13, 2023 | BioWorld Year-to-date money raised in public, private and other financings of biopharma companies. biopharmamoneyraisedjanoct https://www.htsbiopharma.com/products/Acetophenone Acetophenone | HTS Biopharma HTS Biopharma, Hyderabad is an independent contract research organization for worldwide Pharma companies and it is a leading manufacturer in building blocks,... htsbiopharma https://sentrybps.com/2024/08/ August 2024 - Sentry BioPharma Services augustsentrybiopharmaservices https://lebanonscitechweekly.com/article/910785001-crescent-biopharma-to-present-at-may-investor-conferences Crescent Biopharma to Present at May Investor Conferences | Lebanon Sci-Tech Weekly https://www.helixbiopharma.com/2021/07/ July 2021 - Helix Biopharma julyhelixbiopharma https://docs.thermofisher.com/r/Top-Down-Analysis-User-Guide/1201366539v3en-US Remove filters - Remove filters - Top Down Analysis User Guide - BioPharma Finder Software -... If you want to remove one or more filters the you apply to a table, follow the procedure below. Procedure To remove a single filter: In the Results table on... remove filterstop downuser guideanalysisbiopharma https://funderlyst.com/blog/unlocking-the-potential-biopharma-funding-trends-amidst-federal-interest/ - Unlocking the Potential: Biopharma Funding Trends Amidst Federal Interest | FunderLyst Jun 7, 2024 - Biopharma investment trends are shifting, with venture funding jumping to $7.4 billion across 188 deals. Discover more insights now! the potentialfunding trendsunlockingbiopharmaamidst https://resources.industrydive.com/Companion-Diagnostic-Spoiler-Alert-Start-at-the-End-Before-You-Begin Companion Diagnostic Spoiler Alert: Start at the End Before You Begin | BioPharma Dive In this webinar, attendees will gain insights into how they can evaluate potential companion diagnostic partners not just for their development skills but for... start at the end https://pl.bulios.com/ticker/VOR Vor Biopharma Inc. (VOR) Stock | VOR Stock Price & Analysis - Bulios Get the latest news and market analysis for Vor Biopharma Inc. (VOR). Stay up-to-date on VOR Stock price and share price with Bulios. Explore our VOR Stock... stock price analysisvorbiopharmainc https://www.umoja-biopharma.com/team/rimas-orentas-ph-d/ Rimas Orentas, PhD | Umoja Biopharma rimasphdumojabiopharma https://www.biopharmadive.com/news/takeda-fruzaqla-fda-approval-colon-cancer/699290/ Takeda secures FDA approval for colon cancer drug | BioPharma Dive The pharma paid $400 million to license the drug from Hutchmed earlier this year in an effort to bolster its oncology business. fda approvalcolon cancertakedasecuresdrug https://vitrobiopharma.suite.accessnewswire.com/ Media Room of Vitro Biopharma media roomvitrobiopharma https://newmexicohealthreporter.com/article/910785001-crescent-biopharma-to-present-at-may-investor-conferences Crescent Biopharma to Present at May Investor Conferences | New Mexico Health Reporter https://www.biosimilarspipeline.com/shop/tl1002-5x100ml-balanced-salt-solution-with-phenol-red-and-sodium-bicarbonate-1x-22839 Balanced Salt Solution with Phenol red and Sodium bicarbonate / 1X | Biopharma BiosimilarsPipeline balanced salt solutionphenol red https://biopharmaservices.com/blog/bioequivalence-fix-dosed-combination-global-development-strategy-for-value-added-medicine/ Global Development Strategy for Value Added Medicine - BioPharma Services Jun 22, 2023 - Discover BioPharma Service's diverse experience with novel and generic FDC products submitted to different regulatory agencies.- 2026 global developmentvalue addedstrategymedicinebiopharma https://pharmaphorum.com/patients/access-solutions-missing-link-prevents-biopharma-innovation-reaching-patients Access solutions: the missing link that prevents biopharma innovation from reaching patients |... the missing linkaccess solutions https://www.biopharmadive.com/news/bayer-elinzanetant-menopause-drug-results/710686/ With new data, Bayer readies rival to Astellas menopause drug | BioPharma Dive Following a third successful Phase 3 trial, the company is planning approval filings for the medicine, which it acquired in a $425 million deal four years ago. new data https://www.connectbiopharma.com/ Connect Biopharma | Inflammatory Diseases | San Diego, CA, USA Connect Biopharma is a global biopharmaceutical company dedicated to improving the lives of patients with inflammatory diseases. san diego cainflammatory diseasesconnectbiopharmausa https://www.biopharmainfo.net/ Biopharma Informatic | Transforming Healthcare Through Clinical Trials Explore the latest breakthroughs in clinical research, drug trials, and pharmaceutical science. Stay informed with trusted updates on biopharma innovations and... transforming healthcarebiopharmaclinicaltrials https://biopharma.news/arzerra/ Arzerra | BioPharma News biopharmanews https://bulios.com/ticker/NMTR 9 Meters Biopharma, Inc. (NMTR) Stock | NMTR Stock Price & Analysis - Bulios Get the latest news and market analysis for 9 Meters Biopharma, Inc. (NMTR). Stay up-to-date on NMTR Stock price and share price with Bulios. Explore our NMTR... stock price analysismetersbiopharmainc https://biopharmacurated.com/tech-and-innovation/page/3/ Tech & Innovation | Page 3 of 127 | Biopharma Curated tech innovationbiopharmacurated https://www.matinasbiopharma.com/investors/sec-filings/annual-reports/xbrl_doc_only/1949 Matinas BioPharma Holdings, Inc. Annual report pursuant to Section 13 and 15(d) https://www.futunn.com/en/stock/RDHL-US/announcement Redhill Biopharma (RDHL) Latest Announcement & Press Release - Futubull Provide Free Redhill Biopharma (RDHL) announcements. Get the company's latest announcements and press releases. Keep updated on the latest news and major... announcement press releaseredhillbiopharmalatest https://biopharmabytes.com/jpmorgan-s-trucordia-refinancing-boosts-insurance-brokerage-sector/ JPMorgan's Trucordia Refinancing Boosts Insurance Brokerage Sector - Biopharma Bytes Jun 8, 2025 - In the ever-evolving insurance industry, Trucordia is a name that has been making impressive strides. Following strategic acquisitions in 2025, the company has... insurance brokeragejpmorganrefinancingboostssector https://www.biopharmadive.com/press-release/get-started/ Press Release Distribution Service | BioPharma Dive press release distributionservicebiopharmadive https://www.itiger.com/news/2593541883 Quantum Biopharma Announces Completion of Dosing in 180-Day Repeated Dose Oral Toxicity and... Quantum Biopharma Announces Completion of Dosing in 180-Day Repeated Dose Oral Toxicity and Toxicokinetic Studies for Lucid-21-302 (Lucid-MS). On Tiger... https://www.twistbioscience.com/resources/article/twist-biopharma-antibody-candidates-against-gpcr-therapeutic-targets Twist Biopharma: antibody candidates against GPCR therapeutic targets Immunotherapy has the potential to treat a wide variety of conditions, from autoimmune disease to cancer. However, the discovery of potential antibody... twistbiopharmaantibodycandidatesgpcr https://offpharma.com/product/biopharma-myocor-2-5-mg-tablet-bisoprolol-hemifumarate/ Biopharma Myocor 2.5 mg Tablet Bisoprolol Hemifumarate | Off Pharma biopharmamgtabletbisoprolol https://www.fiercebiotech.com/biotech/redhill-biopharma-slides-as-covid-drug-flops-severe-disease RedHill BioPharma follows familiar biotech path after COVID-19 drug fails in severe patients |... Sep 14, 2021 - RedHill Biopharma has rolled snake eyes in a late-stage trial for its experimental COVID-19 treatment, the SK2 inhibitor opaganib, which has failed to help... https://www.cencora.com/initiatives/pharma/supporting-biopharma-breakthroughs Comprehensive Biopharma Support & Solutions | Cencora Partner with Cencora to accelerate drug development, streamline commercialization, and enhance patient access. Discover innovative solutions for global impact. support solutionscomprehensivebiopharmacencora https://www.dorbiopharma.com/shop/zay-g-1058-guinea-pig-spleen-genomic-dna-0-1-mg-48077 Guinea Pig Spleen Genomic DNA - 0.1 mg | DOR BioPharma, Inc. guinea piggenomic dnaspleen https://biopharmaboardroom.com/category/vaccines/page-3.html Latest BioPharma News and In-Depth Analysis | BioPharma BoardRoom Stay ahead of the curve in the biopharma industry with Biopharma Boardroom. Our website offers valuable insights, analysis, and networking opportunities for... biopharma newsand inlatestdepthanalysis https://pharma.economictimes.indiatimes.com/news/pharma-industry/indias-biopharma-crossroads-chemistry-today-biologics-tomorrow/125864938 Unlocking India's Biopharma Potential: From Chemistry to Biologics, ETPharma India Biopharma Innovation: Explore how India can lead in biopharmaceutical innovation as industry leaders discuss the transition from small molecules to... india sunlockingbiopharmapotentialchemistry https://www.biopharmadive.com/news/viatris-ceo-scott-smith-replace-goettler/643597/ Viatris taps new CEO to lead second phase of business revamp | BioPharma Dive Celgene veteran Scott Smith will take over for Michael Goettler on April 1 as the generic drugmaker prepares for a return to growth after divestitures and the... https://www.pharmexec.com/topic/emerging-biopharma Emerging Biopharma | Topic | PharmExec emerging biopharmatopic https://denovobiopharma.com/index_Chinese.html Denovo Biopharma denovobiopharma https://www.galienfoundation.org/prix-galien-bridges Prix Galien Bridges: Celebrating Nordic Innovation in Biopharma Discover Prix Galien Bridges, an awards initiative honoring life sciences innovation in the Nordic region and its collaboration with key global biopharma... prix galien bridgescelebratingnordicinnovationbiopharma https://tajikistantechdaily.com/article/846014420-gt-biopharma-to-participate-in-the-h-c-wainwright-27th-annual-global-investment-conference GT Biopharma to Participate in the H.C. Wainwright 27th Annual Global Investment Conference |... https://immixbio.com/immix-biopharma-doses-1st-patient-in-u-s-al-amyloidosis-trial-with-car-t-nxc-201/ Immix Biopharma Doses 1st Patient in U.S. AL Amyloidosis Trial with CAR-T NXC-201 - IMMIX BIOPHARMA... May 5, 2026 - Lead site Memorial Sloan Kettering Cancer Center (MSKCC)Timing of milestone in-line with mid-2024 guidanceData from ex-US clinical trial reported at ASGCT 2024... https://biopharmabytes.com/tag/microgravity-research/ Microgravity Research Archives - Biopharma Bytes microgravity researcharchivesbiopharmabytes https://www.helixbiopharma.com/gemceda/ GEMCEDA: A Helix Biopharma Cancer Solution Mar 18, 2025 - Learn about the first-in-class oral gemcitabine for cancer therapy, designed to expand disease-limiting and life-enhancing outcomes for advanced cancer patients helixbiopharmacancersolution https://lead-spot.net/blog/what-makes-a-patient-experience-engine-essential-for-biopharma/ What Makes a Patient Experience Engine Essential for Biopharma - LeadSpot Apr 17, 2026 - Biopharma faces a growing imperative to move beyond transactional interactions toward deeply personalized patient engagement. A patient experience engine is a... a patientfor biopharmamakesexperienceengine https://www.healthinsidervirginislands.com/article/864216738-crescent-biopharma-to-present-preclinical-data-for-cr-001-a-pd-1-x-vegf-bispecific-antibody-at-the-society-for-immunotherapy-of-cancer-s-sitc-40th Crescent Biopharma to Present Preclinical Data for CR-001, a PD-1 x VEGF Bispecific Antibody, at... https://www.clinicaltrialsarena.com/uncategorized/newsarray-biopharma-reports-positive-results-phase-ii-trial-asthma-drug/ Array BioPharma reports positive results from Phase II trial of asthma drug - Clinical Trials Arena Feb 21, 2023 - Array BioPharma has reported positive results from a Phase II trial of an oral CRTh2 antagonist, ARRY-502, for mild to moderate persistent allergic asthma. https://www.biopharmadive.com/news/abbvie-withdraw-imbruvica-accelerated-approval/647101/ AbbVie removes two approvals for blood cancer drug Imbruvica | BioPharma Dive In paring back use of Imbruvica, the drugmaker has become the latest developer to voluntarily withdraw indications for a cancer medicine following a setback in... blood cancerabbvieremovestwoapprovals https://ldbiopharma.com/ LD Biopharma Inc. ldbiopharmainc https://www.biopharmadive.com/news/fda-panel-ssri-antidepressant-pregnancy-risks-warning/753586/ FDA panel elevates concerns over antidepressant use during pregnancy | BioPharma Dive Experts on the panel shared many of the same views around SSRIs, arguing the risks of the drugs during pregnancy are greater than currently accepted. fda panelduring pregnancyconcerns https://biopharmaservices.com/volunteer-blog/7-things-every-clinical-trial-volunteer-should-know/ 7 things every clinical trial volunteer should know - BioPharma Services Apr 18, 2023 - Get ready to take note of these tips many clinical trial participants are unaware of and and make the most out of your volunteering experience with us! clinical trialthingseveryvolunteerknow https://optiollc.com/ Optio Biopharma Solutions, LLC – Market Access & Commercialization Services biopharma solutionsmarket accessoptiollccommercialization